Literature DB >> 22314276

ATX and LPA receptor 3 are coordinately up-regulated in lipopolysaccharide-stimulated THP-1 cells through PKR and SPK1-mediated pathways.

Song Li1, Chaoyang Xiong, Junjie Zhang.   

Abstract

Lysophosphatidic acid (LPA) is an important phospholipid mediator in inflammation and immunity. Previously, we showed that autotaxin (ATX), the enzyme producing LPA from lysophosphatidylcholine (LPC), is induced by LPS in THP-1 cells via the activation of PKR, JNK and p38 MAPK. In this study, we find that ATX and LPA receptor 3 (LPA(3)) are coordinately up-regulated in LPS-stimulated THP-1 cells. PKR-mediated activation of JNK1 and p38 MAPK is required for both ATX and LPA(3) up-regulation. SPK1-mediated activation of the PI3K-AKT-β-catenin pathway is essential for ATX induction, while SPK1-mediated ERK activation is required for LPA(3) up-regulation. Either ATX or LPA(3) knockdown inhibited CCL8 induction by LPS, suggesting that ATX and LPA(3) are involved in CCL8 induction during the inflammatory process against bacterial infection. Copyright Â
© 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314276     DOI: 10.1016/j.febslet.2012.01.044

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Biochim Biophys Acta       Date:  2012-07-15

Review 2.  The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.

Authors:  Seung-Jae Kim; Hyung-Geun Moon; Gye Young Park
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-29       Impact factor: 4.698

3.  Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1.

Authors:  Shuhong Sun; Xiaotian Zhang; Lin Lyu; Xixi Li; Siliang Yao; Junjie Zhang
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

4.  Autotaxin downregulates LPS-induced microglia activation and pro-inflammatory cytokines production.

Authors:  Rana Awada; Jean Sébastien Saulnier-Blache; Sandra Grès; Emmanuel Bourdon; Philippe Rondeau; Avinash Parimisetty; Ruben Orihuela; G Jean Harry; Christian Lefebvre d'Hellencourt
Journal:  J Cell Biochem       Date:  2014-12       Impact factor: 4.429

5.  Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation.

Authors:  Jianwen Song; Ming Guan; Zhenwen Zhao; Junjie Zhang
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

6.  Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice.

Authors:  Eva Kritikou; Gijs H M van Puijvelde; Thomas van der Heijden; Peter J van Santbrink; Maarten Swart; Frank H Schaftenaar; Mara J Kröner; Johan Kuiper; Ilze Bot
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

7.  Lysophosphatidic acid receptor mRNA levels in heart and white adipose tissue are associated with obesity in mice and humans.

Authors:  Amy Brown; Intekhab Hossain; Lester J Perez; Carine Nzirorera; Kathleen Tozer; Kenneth D'Souza; Purvi C Trivedi; Christie Aguiar; Alexandra M Yip; Jennifer Shea; Keith R Brunt; Jean-Francois Legare; Ansar Hassan; Thomas Pulinilkunnil; Petra C Kienesberger
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

Review 8.  Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies.

Authors:  Youssef Alhmada; Denis Selimovic; Fadi Murad; Sarah-Lilly Hassan; Youssef Haikel; Mossaad Megahed; Matthias Hannig; Mohamed Hassan
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

Review 9.  Autotaxin in Pathophysiology and Pulmonary Fibrosis.

Authors:  Ioanna Ninou; Christiana Magkrioti; Vassilis Aidinis
Journal:  Front Med (Lausanne)       Date:  2018-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.